filmov
tv
ASCO 2018: Dr. Coleman Shares Insight on Ongoing Research in Ovarian Cancer
Показать описание
Robert L. Coleman, MD, FACOG, FACS, professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, discusses ongoing research in ovarian cancer, presented at the 2018 ASCO Annual Meeting.
0:07:53
ASCO 2018: Dr. Coleman Shares Insight on Ongoing Research in Ovarian Cancer
0:02:51
Gynaecology highlights from ASCO 2018
0:59:36
ASCO 2018 RECAP :: June 2018 Webinar
1:00:42
Living Room Series June 2018: Highlights from ASCO
0:06:35
ASCO 2018: Dr. Birrer on Practice-Changing Ovarian Cancer Studies
0:01:00
Dr. Coleman on the Role of Ramucirumab in Gynecologic Cancer
0:01:35
Dr. Coleman on Immunotherapy in Ovarian Cancer
0:00:53
Gynecologic Oncology at ASCO 2018: Ovarian cancer, JCOG0602, Onda
0:00:18
Copy of Dr. Coleman on Immunotherapy in Ovarian Cancer
0:00:16
Copy of Dr. Coleman on Classifying Patients With Ovarian Cancer
0:01:14
Dr. Coleman on Classifying Patients With Ovarian Cancer
0:38:30
Results from ASCO 2018: Expanding the Reach of Precision Medicine (Part 1)
0:02:05
Dr. Coleman on the Future of PARP Inhibitors in Ovarian Cancer
0:09:27
ASCO 2018: Dr. Borghaei Highlights Immunotherapy Findings in Lung Cancer
0:05:05
ASCO 2018: Dr. Esteva Highlights CDK4/6 Inhibitors and More in Breast Cancer
0:05:32
ASCO 2018: Dr. Westin Sheds Light on PARP Inhibitor Abstracts in Ovarian Cancer
0:02:12
Dr. Coleman on the Use of Veliparib in Advanced Ovarian Cancer
0:03:08
Eleni Andreopoulou, ASCO 2018 – Improving quality of life in patients with breast cancer
0:00:48
SGO Foundation Annual Appeal: Dr. Robert L. Coleman
0:03:29
Dr. Coleman on Advances Made in Ovarian Cancer Treatment
0:02:15
Highlights in urothelial cancer for ASCO GU 2021
0:01:13
Dr. Coleman on Implications of the VELIA Trial in Ovarian Cancer
0:01:14
Dr. Coleman on Rationale for Using Veliparib and Chemotherapy in Ovarian Cancer
0:01:13
Dr. Coleman on Recent Advances and Remaining Questions in Ovarian Cancer
Комментарии